Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

System for delivering microwave ablation to subcutaneous tumors in small-animals under high-field MRI thermometry guidance

J. Sebek, TB. Shrestha, MT. Basel, F. Chamani, N. Zeinali, I. Mali, M. Payne, SA. Timmerman, P. Faridi, M. Pyle, M. O'Halloran, MC. Dennedy, SH. Bossmann, P. Prakash

. 2022 ; 39 (1) : 584-594. [pub] -

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019533

Grantová podpora
R01 EB028848 NIBIB NIH HHS - United States

PURPOSE: Bio-effects following thermal treatments are a function of the achieved temperature profile in tissue, which can be estimated across tumor volumes with real-time MRI thermometry (MRIT). Here, we report on expansion of a previously developed small-animal microwave hyperthermia system integrated with MRIT for delivering thermal ablation to subcutaneously implanted tumors in mice. METHODS: Computational models were employed to assess suitability of the 2.45 GHz microwave applicators for delivering ablation to subcutaneous tumor targets in mice. Phantoms and ex-vivo tissues were heated to temperatures in the range 47-67 °C with custom-made microwave applicators for validating MRIT with the proton resonance frequency shift method against fiberoptic thermometry. HAC15 tumors implanted in nude mice (n = 6) were ablated in vivo and monitored with MRIT in multiple planes. One day post ablation, animals were euthanized, and excised tumors were processed for viability assessment. RESULTS: Average absolute error between temperatures from fiberoptic sensors and MRIT was 0.6 °C across all ex-vivo ablations. During in-vivo experiments, tumors with volumes ranging between 5.4-35.9 mm3 (mean 14.2 mm3) were ablated (duration: 103-150 s) to achieve 55 °C at the tumor boundary. Thermal doses ≥240 CEM43 were achieved across 90.7-98.0% of tumor volumes for four cases. Ablations were incomplete for remaining cases, attributed to motion-affected thermometry. Thermal dose-based ablative tumor coverage agreed with viability assessment of excised tumors. CONCLUSIONS: We have developed a system for delivering microwave ablation to subcutaneous tumors in small animals under MRIT guidance and demonstrated its performance in-vivo.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019533
003      
CZ-PrNML
005      
20220804135739.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/02656736.2022.2061727 $2 doi
035    __
$a (PubMed)35435078
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sebek, Jan $u Department of Electrical and Computer Engineering, Kansas State University, Manhattan, KS, USA $u Department of Circuit Theory, Czech Technical University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000221166697 $7 xx0214491
245    10
$a System for delivering microwave ablation to subcutaneous tumors in small-animals under high-field MRI thermometry guidance / $c J. Sebek, TB. Shrestha, MT. Basel, F. Chamani, N. Zeinali, I. Mali, M. Payne, SA. Timmerman, P. Faridi, M. Pyle, M. O'Halloran, MC. Dennedy, SH. Bossmann, P. Prakash
520    9_
$a PURPOSE: Bio-effects following thermal treatments are a function of the achieved temperature profile in tissue, which can be estimated across tumor volumes with real-time MRI thermometry (MRIT). Here, we report on expansion of a previously developed small-animal microwave hyperthermia system integrated with MRIT for delivering thermal ablation to subcutaneously implanted tumors in mice. METHODS: Computational models were employed to assess suitability of the 2.45 GHz microwave applicators for delivering ablation to subcutaneous tumor targets in mice. Phantoms and ex-vivo tissues were heated to temperatures in the range 47-67 °C with custom-made microwave applicators for validating MRIT with the proton resonance frequency shift method against fiberoptic thermometry. HAC15 tumors implanted in nude mice (n = 6) were ablated in vivo and monitored with MRIT in multiple planes. One day post ablation, animals were euthanized, and excised tumors were processed for viability assessment. RESULTS: Average absolute error between temperatures from fiberoptic sensors and MRIT was 0.6 °C across all ex-vivo ablations. During in-vivo experiments, tumors with volumes ranging between 5.4-35.9 mm3 (mean 14.2 mm3) were ablated (duration: 103-150 s) to achieve 55 °C at the tumor boundary. Thermal doses ≥240 CEM43 were achieved across 90.7-98.0% of tumor volumes for four cases. Ablations were incomplete for remaining cases, attributed to motion-affected thermometry. Thermal dose-based ablative tumor coverage agreed with viability assessment of excised tumors. CONCLUSIONS: We have developed a system for delivering microwave ablation to subcutaneous tumors in small animals under MRIT guidance and demonstrated its performance in-vivo.
650    _2
$a zvířata $7 D000818
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a myši $7 D051379
650    _2
$a myši nahé $7 D008819
650    _2
$a mikrovlny $x terapeutické užití $7 D008872
650    12
$a nádory $x diagnostické zobrazování $x chirurgie $7 D009369
650    12
$a termometrie $7 D062125
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Shrestha, Tej B $u Department of Anatomy and Physiology, Kansas State University, Manhattan, KS, USA
700    1_
$a Basel, Matthew T $u Department of Anatomy and Physiology, Kansas State University, Manhattan, KS, USA
700    1_
$a Chamani, Faraz $u Department of Electrical and Computer Engineering, Kansas State University, Manhattan, KS, USA
700    1_
$a Zeinali, Nooshin $u Department of Electrical and Computer Engineering, Kansas State University, Manhattan, KS, USA
700    1_
$a Mali, Ivina $u Department of Chemistry, Kansas State University, Manhattan, KS, USA
700    1_
$a Payne, Macy $u Department of Chemistry, Kansas State University, Manhattan, KS, USA
700    1_
$a Timmerman, Sarah A $u Department of Anatomy and Physiology, Kansas State University, Manhattan, KS, USA
700    1_
$a Faridi, Pegah $u Department of Electrical and Computer Engineering, Kansas State University, Manhattan, KS, USA
700    1_
$a Pyle, Marla $u Department of Anatomy and Physiology, Kansas State University, Manhattan, KS, USA
700    1_
$a O'Halloran, Martin $u College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Republic of Ireland
700    1_
$a Dennedy, M Conall $u College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Republic of Ireland
700    1_
$a Bossmann, Stefan H $u Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA $1 https://orcid.org/0000000200580127
700    1_
$a Prakash, Punit $u Department of Electrical and Computer Engineering, Kansas State University, Manhattan, KS, USA $1 https://orcid.org/000000016467722X
773    0_
$w MED00002331 $t International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group $x 1464-5157 $g Roč. 39, č. 1 (2022), s. 584-594
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35435078 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135732 $b ABA008
999    __
$a ok $b bmc $g 1822935 $s 1170776
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 39 $c 1 $d 584-594 $e - $i 1464-5157 $m International journal of hyperthermia $n Int J Hyperthermia $x MED00002331
GRA    __
$a R01 EB028848 $p NIBIB NIH HHS $2 United States
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace